Similar Search Results

Understanding Parents’ Child Vaccination Behaviors in the United States

Song, Geoboo - 2017

Acknowledging the growing public health concern caused by the deadly reemergence of vaccine-preventable infectious diseases in the United States, this research focuses on how we can better understand American parents' child vaccination behaviors. The results of an empirical analysis using...

Persistent link: https://www.econbiz.de/10012958404

Planning and Modelling of Pharmaceuticals Wholesale-Distributors Supply Chain Using SCOR Model : A Moroccan Case Study

Essajide, Lhassan - 2017

products requires the pharmaceuticals wholesale-distributors, in order to maintain and improve their performance, to be more … organizational productivity and profitability. This paper presents an adaptation of the SCOR processes to the pharmaceuticals … decisionmaking system in supply chain management of pharmaceuticals wholesale distributors and that consider the uncertainty. SCOR …

Persistent link: https://www.econbiz.de/10012959245

Pharmaceutical Patents and Expropriation in Indian Bilateral Investment Treaties

Ranjan, Prabhash - 2017

This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India's regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory measures such as compulsory licensing of pharmaceutical...

Persistent link: https://www.econbiz.de/10012959457

Evolution of Physician-Industry Relationships in Producing Knowledge of Drug Therapy - Comparison of the United States and Finland

Hemminki, Elina - 2017

This paper presents a historical perspective on the evolution of relationships between the pharmaceutical industry and physicians in two countries, the United States and Finland. Despite divergence early the twentieth century, and the absence of any large pharmaceutical firms based in Finland,...

Persistent link: https://www.econbiz.de/10012959491

Intended and Unintended Consequences of China’s Zero Markup Drug Policy

Yi, Hongmei - 2017

Since economic liberalization in the late 1970s, China's health care providers have grown heavily reliant on revenue from drugs, which they both prescribe and sell. To curb abuse and to promote the availability, safety, and appropriate use of essential drugs, China introduced its national...

Persistent link: https://www.econbiz.de/10012960661

System Dynamics Modeling-Based Analysis of Combating Counterfeit Drugs Supply Chain in India

Bhushan, Sanjay - 2017

The counterfeit drugs supply chain dynamics follow a counterintuitive pattern. Despite it being targeted by law enforcement policies, it has been going on increasing rampantly. This paper proposes a dynamic hypothesis based on systems approach, questioning the very way in which the supplies of...

Persistent link: https://www.econbiz.de/10012960675

Trade Agreements, Patents, and Drug Prices : Continuing the Debate

Kapczynski, Amy - 2017

The upward-ratcheting of patent protection through trade agreements has generated significant concerns about potential effects on prices of drugs and access to medicines in developing countries. The Trans-Pacific Partnership (TPP) included even more extensive pharmaceutical patent provisions...

Persistent link: https://www.econbiz.de/10012960985

Pharmaceutical Patent Wars, Reverse-Payment Settlements, and Their Anticompetitive Effects for Consumers

Adamson, Steven - 2017

Generic drugs have been provided considerable cost-savings to consumers. The Hatch-Waxman Act provides economic incentives to both generic and brand-name manufacturers, but it is a complicated piece of legislation scattered across numerous sections of the United States Code. This obfuscation has...

Persistent link: https://www.econbiz.de/10012961823

Patient Patents

Lichtman, Douglas - 2017

Until recently, successful patent plaintiffs would almost always be awarded injunctions against future infringement. Thanks to a recent change in remedies jurisprudence, however, patent plaintiffs today are often denied injunctions and awarded, instead, ongoing royalties. This change was made...

Persistent link: https://www.econbiz.de/10012961986

Systemic Failure of Regulation : The Political Economy of Pharmaceutical and Bulk Drug Manufacturing

Vijay, Gudavarthy - 2017

This chapter challenges the myth of pharmaceuticals constituting a Sun Rise industry of great potential for the future … pharmaceuticals industry with competitive advantages in international markets. It explains a pattern of systemic regulatory failure … resulting in the bad manufacturing practice of pharmaceuticals and bulk drugs manufacturers dumping untreated toxic and …

Persistent link: https://www.econbiz.de/10012962899